Atlas Trials

A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)

Clinical trial NCT01066598 · TERMINATED

Trial details

NCT number
NCT01066598
Sponsor
University Health Network, Toronto
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2010-05-01
Primary completion
2011-08-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.